SOLV Earnings

SOLV reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 2.00B against an estimate of 2.00B, resulting in a 2.2% surprise. The EPS was 1.5, surpassing the expected 1.43 by 4.9% . The stock experienced a 7.91% price change on the earnings day and a 11.39% change over the next five days, reflecting market reactions to the results.

Following SOLV's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by 7.91% on the day of the release. Over the subsequent five days, it saw a 11.39% change. Historically, SOLV's stock price tends to shift by an average of -0.85% in the 10 days leading up to earnings and +1.68% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate SOLV’s annual revenue to reach 2.00B, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.1% and EPS estimates Revise Downward by -0.03% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between SOLV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.1%, while EPS estimates moved Revise Downward by -0.03% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SOLV's stock price typically moves by -0.85% in the 10 days before its earnings and +1.68% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.00 and revenue of 2.00B.

The earnings call summary and Q&A session indicate a positive outlook. The company raised sales growth and EPS guidance, achieved strong EPS and operating margin, and reduced debt significantly. Management's confidence in achieving long-range growth plans and strategic reinvestments in high-return areas further support positive sentiment. Despite some uncertainties, such as tariff impacts and specific spending details, the overall guidance and financial health suggest a positive stock price reaction over the next two weeks.